What is the recommended management for a pregnant woman with pre-eclampsia (high blood pressure during pregnancy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Preeclampsia

For a pregnant woman diagnosed with preeclampsia, immediate management depends critically on gestational age and disease severity: administer magnesium sulfate for seizure prophylaxis if severe features are present, aggressively control blood pressure to target systolic 110-140 mmHg and diastolic 85 mmHg, and deliver at ≥37 weeks after maternal stabilization—while earlier gestational ages require individualized timing based on maternal-fetal status at a specialized center. 1, 2

Initial Assessment and Risk Stratification

Diagnosis Confirmation

  • Preeclampsia is defined as new-onset hypertension (≥140/90 mmHg) after 20 weeks gestation with either proteinuria (≥300 mg/24 hours or protein/creatinine ratio ≥30 mg/mmol) OR evidence of end-organ damage. 1
  • All cases should be considered potentially severe as they can rapidly progress to life-threatening emergencies within hours. 1, 2
  • Critical pitfall: Do not rely on blood pressure alone to determine severity—serious organ dysfunction can develop at relatively mild BP elevations. 3, 2

Severe Features Assessment

Severe preeclampsia is present with any of the following: 1, 2

  • Severe hypertension: BP ≥160/110 mmHg
  • Neurological symptoms: severe intractable headache, visual scotomata, altered mental status
  • Epigastric or right upper quadrant pain (suggests hepatic capsule distension or HELLP syndrome)
  • Renal dysfunction: creatinine >1.1 mg/dL or oliguria <100 mL/4 hours
  • Thrombocytopenia: platelets <100,000/μL
  • Elevated liver enzymes: AST/ALT >2x upper limit of normal
  • Pulmonary edema

Immediate Management Protocol

Blood Pressure Control

Severe hypertension (≥160/110 mmHg persisting >15 minutes) requires urgent treatment within minutes to prevent maternal stroke. 1, 2

First-line antihypertensive options: 1, 2

  • IV labetalol: 20 mg IV bolus, then 40 mg after 10 minutes, then 80 mg every 10 minutes to maximum 220 mg
  • IV nicardipine or IV hydralazine as alternatives
  • Oral nifedipine is preferred for non-urgent blood pressure control 4

Target blood pressure: systolic 110-140 mmHg, diastolic 85 mmHg. 1, 2 The goal is to decrease mean BP by 15-25% to prevent cerebral hemorrhage while maintaining uteroplacental perfusion. 2

Critical pitfall: Avoid short-acting oral nifedipine when combined with magnesium sulfate due to risk of uncontrolled hypotension and fetal compromise. 2

Seizure Prophylaxis with Magnesium Sulfate

Magnesium sulfate must be administered immediately for: 1, 4, 2

  • All women with severe preeclampsia
  • Any woman with neurological symptoms (severe headache, visual changes)
  • Severe hypertension (≥160/110 mmHg)

Dosing regimen: 4, 2

  • Loading dose: 4-5 g IV over 5 minutes
  • Maintenance: 1-2 g/hour continuous IV infusion
  • Continue for 24 hours postpartum (eclampsia can occur postpartum with 0.6% recurrence rate with magnesium vs 2% without) 4

Monitoring for magnesium toxicity: 2

  • Assess deep tendon reflexes before each dose
  • Monitor respiratory rate (toxicity causes respiratory depression)
  • Hourly urine output via Foley catheter with target ≥100 mL/4 hours

Comprehensive Laboratory Assessment

Obtain immediately: 1, 2

  • Complete blood count (hemoglobin, platelets—thrombocytopenia <100,000/μL suggests HELLP)
  • Comprehensive metabolic panel (AST/ALT, creatinine, uric acid)
  • Spot urine protein/creatinine ratio if not already confirmed

Repeat at least twice weekly or more frequently with clinical deterioration. 2

Fluid Management

Total fluid intake must be strictly limited to 60-80 mL/hour to prevent pulmonary edema. 1, 4 Target urine output 0.5-1 mL/kg/hour or >35 mL/hour. 4, 2

For pulmonary edema: IV nitroglycerin starting at 5 mcg/min, gradually increased every 3-5 minutes to maximum 100 mcg/min. 2 Plasma volume expansion is not recommended. 2

Maternal and Fetal Monitoring

Maternal Monitoring Requirements

Continuous or every 4-hour monitoring includes: 1, 4, 2

  • Blood pressure measurements
  • Oxygen saturation (maternal early warning if <95%)
  • Neurological assessment (agitation, confusion, unresponsiveness)
  • Symptoms: non-remitting headache, visual disturbances, epigastric/RUQ pain, shortness of breath

Fetal Assessment

Electronic fetal heart rate monitoring should be performed continuously or at regular intervals to assess fetal well-being. 4, 2

Ultrasound assessment at diagnosis: 2

  • Fetal biometry, amniotic fluid volume, umbilical artery Doppler
  • Repeat every 2 weeks if initial assessment normal, more frequently if fetal growth restriction present

Delivery Timing: The Definitive Treatment

Delivery is the definitive treatment for preeclampsia. 1, 5, 6 The American College of Obstetricians and Gynecologists provides clear gestational age-based guidelines:

≥37 Weeks Gestation

Immediate delivery is indicated after maternal stabilization with magnesium sulfate and blood pressure control. 1, 2 Induction of labor is associated with improved maternal outcomes. 2

34-37 Weeks Gestation

Expectant conservative management is appropriate if maternal and fetal status remain stable. 3, 2 Deliver if any maternal or fetal deterioration occurs. 2

<34 Weeks Gestation

Conservative expectant management at a center with Maternal-Fetal Medicine expertise. 3, 2 The average interval from diagnosis to delivery at <32 weeks is 14 days, though some require delivery within 72 hours. 2

Administer corticosteroids between 24-34 weeks gestation to reduce neonatal mortality and morbidity. 5

Absolute Indications for Immediate Delivery (Regardless of Gestational Age)

Deliver immediately after maternal stabilization if any of the following develop: 3, 2

  • Inability to control BP despite ≥3 classes of antihypertensives in appropriate doses
  • Maternal pulse oximetry <90% or pulmonary edema
  • Progressive deterioration in liver function, creatinine, hemolysis, or platelet count
  • Ongoing neurological features: severe intractable headache, repeated visual scotomata, or eclampsia
  • Placental abruption
  • Non-reassuring fetal status (reversed end-diastolic flow on umbilical artery Doppler, non-reassuring cardiotocograph, or stillbirth)

Critical pitfall: Do not use serum uric acid or level of proteinuria as indication for delivery. 3, 2

HELLP Syndrome Recognition

HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) carries 3.4% maternal mortality. 4, 2

Hallmark symptom: Epigastric or right upper quadrant pain. 4, 2 This suggests hepatic capsule distension and requires immediate attention.

Monitor glucose intraoperatively as severe hypoglycemia can occur. 2

Postpartum Management

Close monitoring must continue for at least 3 days postpartum as eclampsia can still develop. 1, 4

Postpartum protocol: 4

  • Continue magnesium sulfate for 24 hours postpartum
  • Monitor BP at least every 4-6 hours for at least 3 days
  • Repeat laboratory tests (hemoglobin, platelets, creatinine, liver enzymes) the day after delivery and every other day until stable
  • Avoid NSAIDs for postpartum analgesia, especially with renal dysfunction, as they worsen hypertension and renal function 4

Prevention Strategies

Low-Dose Aspirin for High-Risk Women

The USPSTF recommends low-dose aspirin (81 mg/day) as preventive medication after 12 weeks gestation in women at high risk for preeclampsia. 3 The British Medical Journal suggests initiating before 16 weeks gestation at 75-162 mg/day. 1

High-risk factors include: 3

  • History of eclampsia or preeclampsia (particularly early-onset)
  • Previous adverse pregnancy outcome
  • Maternal comorbid conditions (type 1 or 2 diabetes, gestational diabetes, chronic hypertension, renal disease, autoimmune diseases)
  • Multifetal gestation
  • Nulliparity, obesity, African American race, advanced maternal age

Ineffective Interventions

The following have been shown ineffective and are not recommended: 7

  • Fish oil supplementation
  • Calcium supplementation
  • Vitamin C and E supplementation
  • Prophylactic antihypertensives in women without hypertension

Medications to Absolutely Avoid

ACE inhibitors, ARBs, and direct renin inhibitors are absolutely contraindicated due to severe fetotoxicity. 2

Diuretics are contraindicated as they further reduce plasma volume. 2

Sodium nitroprusside should only be used as last resort for extreme emergencies due to risk of fetal cyanide poisoning. 2

Long-Term Implications

Women with a history of preeclampsia have significantly increased lifetime cardiovascular risk. 1 They require long-term cardiovascular risk assessment and management in the postpartum period and beyond. 7, 8

Screening Recommendations

All pregnant women should undergo blood pressure screening at every prenatal visit throughout pregnancy. 3, 1, 9 The USPSTF gives this a Grade B recommendation with moderate certainty of substantial net benefit. 3, 9

Proper technique: 3

  • Patient relaxed for 5 minutes, sitting position, legs uncrossed, back supported
  • Arm at level of right atrium
  • Use large cuff if upper arm circumference ≥33 cm
  • Avoid measuring in left lateral position (falsely lowers readings)

References

Guideline

Preeclampsia Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severe Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Eclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diagnosis and management of preeclampsia.

American family physician, 2004

Research

Prediction and prevention of recurrent preeclampsia.

Obstetrics and gynecology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.